REPLIGEN CORP - 8-K Filing

Repligen's acquisition of BioLife cleared HSR waiting period on Sept. 3, 2026; stockholder vote scheduled for Oct. 5. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $RGEN

Read the full article at SEC EDGAR

More Regulatory news